Bank of America’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.26M | Sell |
1,348,131
-318,575
| -19% | -$463K | ﹤0.01% | 4129 |
|
|
2026
Q1 | $2.2M | Sell |
1,666,706
-188,108
| -10% | -$337K | ﹤0.01% | 4060 |
|
|
2025
Q4 | $3.47M | Buy |
1,854,814
+382,124
| +26% | +$734K | ﹤0.01% | 3665 |
|
|
2025
Q3 | $1.89M | Buy |
1,472,690
+769,987
| +110% | +$1.04M | ﹤0.01% | 4864 |
|
|
2025
Q2 | $871K | Sell |
702,703
-154,352
| -18% | -$178K | ﹤0.01% | 5384 |
|
|
2025
Q1 | $1.01M | Sell |
857,055
-1,357,458
| -61% | -$2.08M | ﹤0.01% | 5207 |
|
|
2024
Q4 | $4.05M | Sell |
2,214,513
-139,334
| -6% | -$272K | ﹤0.01% | 3785 |
|
|
2024
Q3 | $4M | Buy |
2,353,847
+489,954
| +26% | +$805K | ﹤0.01% | 3954 |
|
|
2024
Q2 | $2.55M | Buy |
1,863,893
+264,750
| +17% | +$535K | ﹤0.01% | 4244 |
|
|
2024
Q1 | $6M | Buy |
1,599,143
+776,098
| +94% | +$4.54M | ﹤0.01% | 3451 |
|
|
2023
Q4 | $8.07M | Sell |
823,045
-755
| -0.1% | -$6.17K | ﹤0.01% | 3109 |
|
|
2023
Q3 | $6.88M | Buy |
823,800
+226,080
| +38% | +$2.58M | ﹤0.01% | 3106 |
|
|
2023
Q2 | $7.95M | Sell |
597,720
-242,167
| -29% | -$2.94M | ﹤0.01% | 2943 |
|
|
2023
Q1 | $9.73M | Buy |
839,887
+303,904
| +57% | +$3.02M | ﹤0.01% | 2854 |
|
|
2022
Q4 | $4.38M | Sell |
535,983
-81,969
| -13% | -$706K | ﹤0.01% | 3512 |
|
|
2022
Q3 | $3.59M | Sell |
617,952
-434,781
| -41% | -$2.49M | ﹤0.01% | 3693 |
|
|
2022
Q2 | $4.65M | Buy |
1,052,733
+458,902
| +77% | +$2.79M | ﹤0.01% | 3479 |
|
|
2022
Q1 | $5.4M | Buy |
593,831
+137,847
| +30% | +$1.59M | ﹤0.01% | 3536 |
|
|
2021
Q4 | $9.33M | Buy |
455,984
+196,212
| +76% | +$4.74M | ﹤0.01% | 2997 |
|
|
2021
Q3 | $6.64M | Sell |
259,772
-20,024
| -7% | -$593K | ﹤0.01% | 3281 |
|
|
2021
Q2 | $9.78M | Sell |
279,796
-3,740
| -1% | -$109K | ﹤0.01% | 2882 |
|
|
2021
Q1 | $9.44M | Buy |
283,536
+214,072
| +308% | +$7.49M | ﹤0.01% | 2783 |
|
|
2020
Q4 | $1.8M | Buy |
69,464
+16,206
| +30% | +$275K | ﹤0.01% | 4039 |
|
|
2020
Q3 | $526K | Sell |
53,258
-76,731
| -59% | -$442K | ﹤0.01% | 4669 |
|
|
2020
Q2 | $448K | Buy |
129,989
+12,196
| +10% | +$41.5K | ﹤0.01% | 4700 |
|
|
2020
Q1 | $360K | Buy |
117,793
+17,943
| +18% | +$73.5K | ﹤0.01% | 4737 |
|
|
2019
Q4 | $513K | Buy |
99,850
+2,539
| +3% | +$12.9K | ﹤0.01% | 4997 |
|
|
2019
Q3 | $502K | Sell |
97,311
-43,586
| -31% | -$244K | ﹤0.01% | 5079 |
|
|
2019
Q2 | $853K | Buy |
140,897
+30,071
| +27% | +$211K | ﹤0.01% | 4686 |
|
|
2019
Q1 | $801K | Buy |
110,826
+39,884
| +56% | +$288K | ﹤0.01% | 4688 |
|
|
2018
Q4 | $525K | Buy |
70,942
+45,020
| +174% | +$285K | ﹤0.01% | 4897 |
|
|
2018
Q3 | $140K | Buy |
25,922
+9,365
| +57% | +$40.2K | ﹤0.01% | 5690 |
|
|
2018
Q2 | $58K | Sell |
16,557
-324,818
| -95% | -$901K | ﹤0.01% | 6065 |
|
|
2018
Q1 | $699K | Buy |
341,375
+229,231
| +204% | +$595K | ﹤0.01% | 4615 |
|
|
2017
Q4 | $296K | Buy |
112,144
+50,352
| +81% | +$176K | ﹤0.01% | 5232 |
|
|
2017
Q3 | $325K | Buy |
61,792
+19,637
| +47% | +$84.4K | ﹤0.01% | 5180 |
|
|
2017
Q2 | $150K | Sell |
42,155
-8,107
| -16% | -$32.7K | ﹤0.01% | 5437 |
|
|
2017
Q1 | $260K | Buy |
50,262
+34,824
| +226% | +$170K | ﹤0.01% | 5203 |
|
|
2016
Q4 | $58K | Sell |
15,438
-37,736
| -71% | -$274K | ﹤0.01% | 5866 |
|
|
2016
Q3 | $477K | Buy |
53,174
+32,796
| +161% | +$274K | ﹤0.01% | 4660 |
|
|
2016
Q2 | $143K | Buy |
20,378
+2,537
| +14% | +$23.2K | ﹤0.01% | 5371 |
|
|
2016
Q1 | $152K | Buy |
17,841
+76
| +0.4% | +$747 | ﹤0.01% | 5284 |
|
|
2015
Q4 | $234K | Buy |
17,765
+14,547
| +452% | +$131K | ﹤0.01% | 5285 |
|
|
2015
Q3 | $12K | Sell |
3,218
-8,725
| -73% | -$42.7K | ﹤0.01% | 6504 |
|
|
2015
Q2 | $69K | Buy |
11,943
+8,943
| +298% | +$51.7K | ﹤0.01% | 5788 |
|
|
2015
Q1 | $18K | Sell |
3,000
-10,700
| -78% | -$73.8K | ﹤0.01% | 6089 |
|
|
2014
Q4 | $107K | Sell |
13,700
-35,508
| -72% | -$227K | ﹤0.01% | 5831 |
|
|
2014
Q3 | $242K | Buy |
49,208
+42,168
| +599% | +$220K | ﹤0.01% | 5222 |
|
|
2014
Q2 | $44K | Sell |
7,040
-43,120
| -86% | -$216K | ﹤0.01% | 6743 |
|
|
2014
Q1 | $268K | Buy |
50,160
+7,625
| +18% | +$48.2K | ﹤0.01% | 5178 |
|
|
2013
Q4 | $223K | Buy |
42,535
+25,144
| +145% | +$115K | ﹤0.01% | 5488 |
|
|
2013
Q3 | $96K | Buy |
17,391
+7,510
| +76% | +$26.1K | ﹤0.01% | 6004 |
|
|
2013
Q2 | $25K | Buy |
+9,881
| New | +$24.6K | ﹤0.01% | 6879 |
|
Other funds holding PACB
AIM
NAMA
Bank of America's PACB Position: Q2 2026 in Review
Bank of America reduced its Pacific Biosciences (PACB) stake by 19% in Q2 2026, selling an estimated $463K and leaving 1,348,131 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #4129.
Bank of America first reported a position in PACB in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.78M in Q2 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.
- Bank of America held 1,348,131 shares of Pacific Biosciences worth $2.26M as of Q2 2026.
- Bank of America sold 318,575 Pacific Biosciences shares in Q2 2026, an estimated $463K.
- Pacific Biosciences made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4129 holding.
- Bank of America first reported a position in Pacific Biosciences in Q2 2013 and has held it in 53 quarters since.
- Bank of America's Pacific Biosciences position peaked at $9.78M in Q2 2021.
- 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.